Rhinostics and LVL technologies Partner to Provide Decapping Solutions for Automated Collection Device Workflows
Rhinostics Inc. is excited to announce an expanded partnership with LVL technologies GmbH, which includes Rhinostics’ reselling of LVL’s decapper instrument and LVL’s distribution of Rhinostics’ automated collection devices in Germany and Austria. By combining the Rhinostics’ sample collection device ingenuity with decapper technology, laboratories can benefit from an instantly scalable automated swab and small volume blood collection processing workflow. Automation breaks through manual bottlenecks during capping and recapping steps so that laboratories can increase throughput and consistency while also decreasing cumbersome steps as well as reagent and labor costs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221114005373/en/
Rhinostics and LVL technologies Partner to Provide Decapping Solutions for Automated Collection Device Workflows (Photo: Business Wire)
“Today, researchers, clinicians, and patients alike expect more when it comes to sample collection and diagnostic workflows from respiratory pathogens, sexually transmitted infections, genetic testing to cancer biomarkers and much more,” explained Cheri Walker, PhD, President and CEO of Rhinostics. “We’re excited to expand our partnership with LVL, our supplier of high-quality collection tubes to Rhinostics during the pandemic and beyond. The companies have enjoyed a close relationship, and we can now offer a full solution for our customers by launching a customized version of LVL’s robust decapper instrument to the market.”
“We are extremely pleased to expand our partnership with Rhinostics,” said Martin von Lueder, Chief Executive Officer of LVL. “We have watched Rhinostics bring industry changing, purpose-built sample collection devices that are automation-enabled to the market. The LVL decapper instrument is the perfect complement to their consumables, allowing improvements to inefficient swab and blood collection workflows. Additionally, we look forward to offering the Rhinostics products to our customers.”
As part of the partnership, the RHINObot™ has been optimized for use with the RHINOstic® Automated Swab – a patent-pending sample collection device that integrates a unique polypropylene-based swab with an automatable cap.
Nasal, buccal, or vaginal samples may be comfortably collected in a clinical setting or easily self-collected as part of an at-home test kit. After collection, the swab is securely screwed into a small, barcoded transport tube. This transport tube may be shipped without use of viral transport or other media to reduce reagent costs as well as risks of leaking, accidental biohazard exposure, and potential PCR interference due to VTM or other media components. Dry shipment also enables greater sample concentrations to boost confidence in sensitive PCR, next generation sequencing (NGS), ELISA methods, even at very low pathogen levels.
Once in the laboratory, samples may be loaded onto the RHINObot™ for automated decapping and capping of up to 96 samples in less than 1 minute. This hands-free workflow eliminates user variability and reduces labor time by up to 80+% to significantly decrease per-test costs.
The collaborative agreement will include co-promoting the RHINOstic® and RHINObot™ solution along with marketing and educational initiatives aimed at making customers aware of the increased convenience, speed, and consistency of the automated workflow.
Rhinostics is at the forefront of revolutionizing sample collection. As a spin-out company from Harvard University and Wyss Institute, we are taking a radical new approach to sample collection device design and function. COVID-19 cast light on the urgent need to improve laboratory workflows. Rhinostics was born to meet the moment. Our united mission is to revolutionize laboratory workflows, one purpose-built collection device at a time. We improve sample collection comfort and performance while bringing efficiencies to the laboratory to remove costs and save time compared to traditional sample collection intake. Our groundbreaking technologies include functional design, novel materials, and automation solutions for removing caps and rapid accessioning for hands-free workflows. This enables robust high-throughput assays from start to finish with minimal human intervention, saving time and reducing costs.
Rhinostics’ initial product, the RHINOstic® Automated Swab, aids testing broad diagnostic and life science workflows, in areas like respiratory disease, genomics, STDs, forensics and much more. The company continues to innovate, launching a novel small-volume blood collection device, the VERIstic™, and developing a pipeline of novel sample collection devices that are purpose-built for their application combined with automation enablement. To learn more, visit https://www.rhinostics.com.
LVL technologies is a leading global manufacturer of 2D coded tubes in the automation-friendly SBS format, including the necessary technical infrastructure. Based in Crailsheim, Germany, the company supplies organizations and companies in more than 50 countries with high-quality storage tubes for demanding long-term sample storage. Applications range from clinical and veterinary diagnostics and biobanking to compound management and research applications in biotechnology. The latest technical development is the fully automatic TLM 864 Tube Laser Marker.
To learn more, visit https://www.lvl-technologies.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Cheri Walker, Rhinostics, Inc.
Tobias Haessner, LVL technologies GmbH & Co. KG
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Hybrid Exchange Ankex Delivers High-Performance Crypto Trading From Secure Self-Custody29.11.2022 18:02:00 EET | Press release
Ankex announces the launch of a new kind of hybrid crypto derivatives exchange which offers sophisticated trading and transparency from the secure self-custody of a decentralized wallet. The launch comes at a time when recent events have shattered investor confidence and drawn attention to the major security and performance trade-offs that investors are forced to accept when trading on either centralized or decentralized cryptoasset exchanges. Whilst centralized exchanges typically offer deeper liquidity, lower latency, and tighter spreads, investors are forced to surrender their funds to an exchange-managed wallet which is vulnerable to hacking or malpractice. Ankex’s hybrid model removes this trade-off, enabling high-performance trading from secure self-custody, one of the main benefits of decentralized exchanges. When trading on Ankex, user assets remain in secure wallets (“Vaults”) protected by Qredo’s decentralized MPC (dMPC) and located on its Layer 2 blockchain. Because no asset
ADVA named Titanium partner in Intel® Network Builders Winners’ Circle29.11.2022 18:00:00 EET | Press release
ADVA (FSE: ADV) today announced that it has been named to the Intel® Network Builders Winners’ Circle at the highest level. ADVA was awarded Titanium status for its carrier-class Ensemble Connector NFV platform and for being an Intel partner who has demonstrated outstanding innovation and business acumen. The open and cloud-native Ensemble Connector platform gives communication service providers (CSPs) and enterprises a simple and cost-efficient route to virtualization at the network edge. It provides platform security, zero-touch provisioning, access to the market’s most comprehensive library of VNFs, and support for a wide variety of third-party servers based on Intel® architecture processors and interfaces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221129005704/en/ Prayson Pate, CTO, Edge Cloud, ADVA (Photo: Business Wire) “Since becoming a software option for Intel® Select Solutions for uCPE, many more customers hav
Xpansiv Launches CBL Auctions to Provide a Transparent, Efficient, Fair Platform for Scaling Carbon Credit Transactions29.11.2022 17:00:00 EET | Press release
Xpansiv, the premier market-infrastructure platform for environmental commodities, today announced the launch of CBL Auctions. As the world’s largest carbon-offset exchange, Xpansiv market CBL offers real-time insight into voluntary carbon, including quotes, portfolio tracking, charting, OTC trading, and now an electronic auction service that helps project developers earn top dollar for their carbon credits. “CBL is the world’s first trading platform to integrate with 24 registries and provide more than 200 environmental spot commodities on a single screen,” said Russell Karas, Xpansiv Head of Carbon Market Development. “Now with CBL Auctions, participants can choose from a variety of auction types, leveraging CBL’s infrastructure for credits and payment transfers. We make it easy to customize your delivery terms and products, or you can use standardized CBL instruments to simplify the process.” CBL Auctions is designed to streamline the process of marketing and selling carbon credits.
Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making29.11.2022 16:50:00 EET | Press release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will incorporate Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion software, into the Viz.ai platform. “We are thrilled to join forces with another revolutionary technology company like Cercare,” said Steve Sweeny, vice president of business development and strategy at Viz.ai. “This partnership is another example of our continued commitment to work with leading, like-minded, innovative companies to enable quick access to important patient data and ultimately improve clinical impact with our Viz platform.” Viz is broadening its imaging features and functionality to best serve institutions that perform MR imaging in the patient workflow. The infusion of Cercare Perfusion technology into the Viz.ai platform enhances the company’s flagship AI-powered
Hyatt Continues Asset-Light Growth Strategy with Plans to Acquire Dream Hotel Group29.11.2022 16:45:00 EET | Press release
Hyatt Hotels Corporation (NYSE: H) and Dream Hotel Group announced an agreement for a Hyatt affiliate to acquire Dream Hotel Group’s lifestyle hotel brand and management platform including the Dream Hotels, The Chatwal Hotels and Unscripted Hotels brands, with properties in some of the world’s most prominent hotel markets across the Americas, Europe and Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221129005474/en/ Dream Downtown (Photo: Business Wire) This asset-light acquisition will include a portfolio of 12 managed or franchised lifestyle hotels, with another 24 signed long-term management agreements for hotels expected to open in the future. Upon closing, this expansion will add over 1,700 rooms to Hyatt’s lifestyle portfolio and increase Hyatt’s room count in New York City by more than 30%. This acquisition continues Hyatt’s asset-light growth strategy following its transactions to acquire Two Roads Hospitality
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom